Clovis Oncology to Present at the Barclays Global Healthcare Conference

BOULDER, Colo.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24CLVS&src=ctag” target=”_blank”gt;$CLVSlt;/agt;–Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief
Executive Officer and President, Patrick J. Mahaffy, will present at the
Barclays Global Healthcare Conference on Wednesday, March 13, 2019 at
11:15 a.m. Eastern time. The conference will be held at the Loews Miami
Beach Hotel in Miami.

A live webcast of the presentation can be accessed through the investor
relations section of the Company’s website at www.clovisoncology.com.
Following the live presentation, a replay of the webcast will be
available on the Company’s website for 30 days.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado; please visit www.clovisoncology.com
for more information, including additional office locations in the U.S.
and Europe.

Contacts

Clovis Oncology
Anna Sussman
303.625.5022
asussman@clovisoncology.com
or
Breanna
Burkart
303.625.5023
bburkart@clovisoncology.com

Leave a Reply

Sky Optics Media drone video